Meeder Asset Management’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-54
| Closed | -$11K | – | 2568 |
|
|
2020
Q1 | $11K | Buy |
54
+25
| +86% | +$5.09K | ﹤0.01% | 1493 |
|
|
2019
Q4 | $13K | Buy |
29
+9
| +45% | +$4.03K | ﹤0.01% | 1495 |
|
|
2019
Q3 | $6K | Hold |
20
| – | – | ﹤0.01% | 1723 |
|
|
2019
Q2 | $6K | Hold |
20
| – | – | ﹤0.01% | 1628 |
|
|
2019
Q1 | $8K | Sell |
20
-10
| -33% | -$4K | ﹤0.01% | 1306 |
|
|
2018
Q4 | $9K | Hold |
30
| – | – | ﹤0.01% | 1286 |
|
|
2018
Q3 | $11K | Buy |
30
+23
| +329% | +$8.43K | ﹤0.01% | 1146 |
|
|
2018
Q2 | $2.49K | Sell |
7
-9
| -56% | -$3.2K | ﹤0.01% | 1390 |
|
|
2018
Q1 | $5K | Sell |
16
-1
| -6% | -$313 | ﹤0.01% | 1244 |
|
|
2017
Q4 | $7K | Sell |
17
-6
| -26% | -$2.47K | ﹤0.01% | 1236 |
|
|
2017
Q3 | $7K | Buy |
23
+7
| +44% | +$2.13K | ﹤0.01% | 1174 |
|
|
2017
Q2 | $4K | Hold |
16
| – | – | ﹤0.01% | 1284 |
|
|
2017
Q1 | $5K | Sell |
16
-3
| -16% | -$938 | ﹤0.01% | 1106 |
|
|
2016
Q4 | $7K | Buy |
+19
| New | +$7K | ﹤0.01% | 819 |
|